SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Wesby van Swaay E.)
 

Search: WFRF:(Wesby van Swaay E.) > (2017) > Infection rates in ...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00005493naa a2200877 4500
001oai:gup.ub.gu.se/260036
003SwePub
008240910s2017 | |||||||||||000 ||eng|
009oai:prod.swepub.kib.ki.se:229081988
024a https://gup.ub.gu.se/publication/2600362 URI
024a https://doi.org/10.1136/rmdopen-2017-0004982 DOI
024a http://kipublications.ki.se/Default.aspx?queryparsed=id:2290819882 URI
040 a (SwePub)gud (SwePub)ki
041 a eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
100a Yamanaka, H.4 aut
2451 0a Infection rates in patients from five rheumatoid arthritis (RA) registries: Contextualising an RA clinical trial programme
264 c 2017-10-10
264 1b BMJ,c 2017
520 a Objective Patients with rheumatoid arthritis (RA) have an increased risk of serious infections. Comparing infection rates across RA populations is complicated by differences in background infection risk, population composition and study methodology. We measured infection rates from five RA registries globally, with the aim to contextualise infection rates from an RA clinical trials population. Methods We used data from Consortium of Rheumatology Research of North America (CORRONA) (USA), Swedish Rheumatology Quality of Care Register (Sweden), Norfolk Arthritis Register (UK), CORRONA International (multiple countries) and Institute of Rheumatology Rheumatoid Arthritis (Japan) and an RA clinical trial programme (fostamatinib). Within each registry, we analysed a main cohort of all patients with RA from January 2000 to last available data. Infection definitions were harmonised across registries. Sensitivity analyses to address potential confounding explored subcohorts defined by disease activity, treatment change and/or prior comorbidities and restriction by calendar time or follow-up. Rates of infections were estimated and standardised to the trial population for age/sex and, in one sensitivity analysis also, for Health Assessment Questionnaire (HAQ) score. Results Overall, age/sex-standardised rates of hospitalised infection were quite consistent across registries (range 1.14-1.62 per 100 patient-years). Higher and more consistent rates across registries and with the trial programme overall were seen when adding standardisation for HAQ score (registry range 1.86-2.18, trials rate 2.92) or restricting to a treatment initiation subcohort followed for 18 months (registry range 0.99-2.84, trials rate 2.74). Conclusion This prospective, coordinated analysis of RA registries provided incidence rate estimates for infection events to contextualise infection rates from an RA clinical trial programme and demonstrated relative comparability of hospitalised infection rates across registries. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Reumatologi och inflammation0 (SwePub)302102 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Rheumatology and Autoimmunity0 (SwePub)302102 hsv//eng
653 a epidemiology
653 a infections
653 a outcomes research
653 a rheumatoid arthritis
653 a adult
653 a age
653 a aged
653 a Article
653 a clinical trial
653 a cohort analysis
653 a comorbidity
653 a disease activity
653 a disease registry
653 a female
653 a follow up
653 a gender
653 a Health Assessment Questionnaire
653 a hospital infection
653 a human
653 a incidence
653 a infection rate
653 a infection risk
653 a major clinical study
653 a male
653 a middle aged
653 a prospective study
653 a sensitivity analysis
700a Askling, J.u Karolinska Institutet4 aut
700a Berglind, N.4 aut
700a Franzen, S.4 aut
700a Frisell, T.u Karolinska Institutet4 aut
700a Garwood, C.4 aut
700a Greenberg, J. D.4 aut
700a Ho, M.4 aut
700a Holmqvist, M.u Karolinska Institutet4 aut
700a Novelli Horne, L.4 aut
700a Inoue, E.4 aut
700a Michaud, K.4 aut
700a Pappas, D. A.4 aut
700a Reed, G.4 aut
700a Symmons, D.4 aut
700a Tanaka, E.4 aut
700a Tran, T. N.4 aut
700a Verstappen, S. M. M.4 aut
700a Wesby-Van Swaay, E.4 aut
700a Nyberg, Fredrik,d 1961u Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för samhällsmedicin och folkhälsa, enheten för arbets-och miljömedicin,Institute of Medicine, Department of Public Health and Community Medicine, Section of Occupational and environmental medicine4 aut0 (Swepub:gu)xnybef
710a Karolinska Institutetb Institutionen för medicin, avdelningen för samhällsmedicin och folkhälsa, enheten för arbets-och miljömedicin4 org
773t RMD Opend : BMJg 3:2q 3:2x 2056-5933
856u https://rmdopen.bmj.com/content/rmdopen/3/2/e000498.full.pdf
8564 8u https://gup.ub.gu.se/publication/260036
8564 8u https://doi.org/10.1136/rmdopen-2017-000498
8564 8u http://kipublications.ki.se/Default.aspx?queryparsed=id:229081988

Find in a library

  • RMD Open (Search for host publication in LIBRIS)

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view